Kanada - enska - Health Canada

dominion pharmacal - meloxicam - tablet - 7.5mg - meloxicam 7.5mg - other nonsteroidal antiimflammatory agents

Kanada - enska - Health Canada

dominion pharmacal - meloxicam - tablet - 15mg - meloxicam 15mg - other nonsteroidal antiimflammatory agents

Kanada - enska - Health Canada

auro pharma inc - meloxicam - tablet - 7.5mg - meloxicam 7.5mg - other nonsteroidal antiimflammatory agents

Kanada - enska - Health Canada

auro pharma inc - meloxicam - tablet - 15mg - meloxicam 15mg - other nonsteroidal antiimflammatory agents

Bandaríkin - enska - NLM (National Library of Medicine)

st. mary's medical park pharmacy - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam tablets are indicated for relief of the signs and symptoms of osteoarthritis [ see clinical studies ( 14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis [ see clinical studies ( 14.1) ]. meloxicam tablets are indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [ see dosage and administration ( 2.4) and clinical studies ( 14.2) ]. meloxicam tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [ see warnings and precautions ( 5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reac

Bandaríkin - enska - NLM (National Library of Medicine)

contract pharmacy services-pa - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 7.5 mg - meloxicam is indicated for relief of the signs and symptoms of osteoarthritis [ see clinical studies (14.1)]. meloxicam is indicated for relief of the signs and symptoms of rheumatoid arthritis [ see clinical studies (14.1) ]. meloxicam is indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weighs ≥ 60 kg [ see dosage and administration ( 2.4) and clinical studies (14.2)]. meloxicam is contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [ see warnings and precautions ( 5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometime

Bandaríkin - enska - NLM (National Library of Medicine)

strides pharma science limited - meloxicam (unii: vg2qf83cgl) (meloxicam - unii:vg2qf83cgl) - meloxicam 7.5 mg - meloxicam tablets, usp is indicated for relief of the signs and symptoms of osteoarthritis [see clinical studies (14.1) ]. meloxicam tablets, usp is indicated for relief of the signs and symptoms of rheumatoid arthritis [see clinical studies (14.1) ]. meloxicam tablets, usp is indicated for relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients who weigh ≥60 kg [see dosage and administration (2.4) and clinical studies (14.2) ]. meloxicam tablets are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to meloxicam or any components of the drug product [see warnings and precautions (5.7, 5.9) ] - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7,5.8) ] - in the setting

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - meloxicam -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - meloxicam -

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - meloxicam, quantity: 7.5 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; microcrystalline cellulose; lactose monohydrate; crospovidone; colloidal anhydrous silica; sodium citrate dihydrate - meloxicam is indicated for symptomatic treatment of osteoarthritis and rheumatoid arthritis.